Followers

August 17, 2024

Pfizer, BioNtech say combined flu-COVID vaccine misses a main goal of Phase 3 trial

​The drugmakers said on Friday the Phase 3 trial showed the vaccine elicited a robust influenza A immune response, compared to a standard flu vaccine, but showed weaker results against the influenza B strain. The formulation showed similar responses against SARS-CoV-2 as the companies' COVID-19 vaccine.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/GNs6ct4

No comments:

Post a Comment